Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.
Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results
Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...
Psychology Today2h
Three Ways New Weight Loss Drugs May Improve Depression
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
Weight-loss drugs: A game changer for India’s top pharma companies
Unless you’ve been living under a rock, you know that weight-loss drugs are the talk of the town. GLP-1 drugs, in particular, ...
WHYY2d
Greater Philly’s largest health insurer to restrict coverage for weight loss medications, citing ‘exorbitant costs’
Independence Blue Cross joins other insurance companies in restricting coverage of Wegovy and Ozempic to Type 2 diabetes and ...
studyfinds4h
Weight loss drugs help with fat loss – but they cause bone and muscle loss too
Explore the world of weight loss drugs. Find out how GLP-1-based drugs can lead to significant weight loss, but also bone and ...
Some patients want to take a holiday pause on diabetes or weight-loss drugs. Here’s what doctors say they need to know
Around the holidays – when many people are baking cookies for Santa, enjoying cocktail parties or having festive family feasts – some adults who use popular medications for diabetes or weight loss ...
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
Half a million people buying weight-loss jabs online because of ‘slow’ NHS rollout
More than half a million people are buying weight-loss injections online because of the “slow” rollout of the drugs by the ...